Abstract
We present preliminary results which encourage KL‐6 evaluation as a potential biomarker for phenotyping COVID-19 patients according to disease severity.
Recommended Citation
Scarpati, Giuliana
(2020)
"KL-6 levels in COVID-19,"
Translational Medicine @ UniSa: Vol. 23
:
Iss.
4
, Article 14.
Available at:
https://doi.org/10.37825/2239-9747.1014
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
COinS